ModelEdge

Karyopharm Therapeutics Inc.
KPTI
Filing Type8-K
Filing Date10/7/2025
Updated10/8/25, 5:05 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Financial Results, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD, Other Events
EX-99.1Material Contracts, Financial Results, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD, Other Events
GRAPHICGraphic